
Article Menu
- Subscribe SciFeed
- Recommended Articles
- Related Info Links
-
More by Authors Links
- on DOAJ
- Monti, M.
- Morgagni, P.
- Nanni, O.
- Framarini, M.
- Saragoni, L.
- Marrelli, D.
- Roviello, F.
- Petrioli, R.
- Fumagalli Romario, U.
- Rimassa, L.
- Bozzarelli, S.
- Donini, A.
- Graziosi, L.
- De Angelis, V.
- De Manzoni, G.
- Bencivenga, M.
- Mengardo, V.
- Parma, E.
- Milandri, C.
- Mura, G.
- Signorini, A.
- Baiocchi, G.
- Molfino, S.
- Sgroi, G.
- Steccanella, F.
- Rausei, S.
- Proserpio, I.
- Viganò, J.
- Brugnatelli, S.
- Rinnovati, A.
- Santi, S.
- Ercolani, G.
- Foca, F.
- Valmorri, L.
- Amadori, D.
- Frassineti, G. Luca
- on Google Scholar
- Monti, M.
- Morgagni, P.
- Nanni, O.
- Framarini, M.
- Saragoni, L.
- Marrelli, D.
- Roviello, F.
- Petrioli, R.
- Fumagalli Romario, U.
- Rimassa, L.
- Bozzarelli, S.
- Donini, A.
- Graziosi, L.
- De Angelis, V.
- De Manzoni, G.
- Bencivenga, M.
- Mengardo, V.
- Parma, E.
- Milandri, C.
- Mura, G.
- Signorini, A.
- Baiocchi, G.
- Molfino, S.
- Sgroi, G.
- Steccanella, F.
- Rausei, S.
- Proserpio, I.
- Viganò, J.
- Brugnatelli, S.
- Rinnovati, A.
- Santi, S.
- Ercolani, G.
- Foca, F.
- Valmorri, L.
- Amadori, D.
- Frassineti, G. Luca
- on PubMed
- Monti, M.
- Morgagni, P.
- Nanni, O.
- Framarini, M.
- Saragoni, L.
- Marrelli, D.
- Roviello, F.
- Petrioli, R.
- Fumagalli Romario, U.
- Rimassa, L.
- Bozzarelli, S.
- Donini, A.
- Graziosi, L.
- De Angelis, V.
- De Manzoni, G.
- Bencivenga, M.
- Mengardo, V.
- Parma, E.
- Milandri, C.
- Mura, G.
- Signorini, A.
- Baiocchi, G.
- Molfino, S.
- Sgroi, G.
- Steccanella, F.
- Rausei, S.
- Proserpio, I.
- Viganò, J.
- Brugnatelli, S.
- Rinnovati, A.
- Santi, S.
- Ercolani, G.
- Foca, F.
- Valmorri, L.
- Amadori, D.
- Frassineti, G. Luca
Need Help?
Order Article Reprints
Journal: Cancers, 2020
Volume: 12
Number: 2790
2790
Article:
Preoperative or Perioperative Docetaxel, Oxaliplatin, and Capecitabine (GASTRODOC Regimen) in Patients with Locally-Advanced Resectable Gastric Cancer: A Randomized Phase-II Trial
Authors:
by
Manlio Monti, Paolo Morgagni, Oriana Nanni, Massimo Framarini, Luca Saragoni, Daniele Marrelli, Franco Roviello, Roberto Petrioli, Uberto Fumagalli Romario, Lorenza Rimassa, Silvia Bozzarelli, Annibale Donini, Luigina Graziosi, Verena De Angelis, Giovanni De Manzoni, Maria Bencivenga, Valentina Mengardo, Emilio Parma, Carlo Milandri, Gianni Mura, Alessandra Signorini, Gianluca Baiocchi, Sarah Molfino, Giovanni Sgroi, Francesca Steccanella, Stefano Rausei, Ilaria Proserpio, Jacopo Viganò, Silvia Brugnatelli, Andrea Rinnovati, Stefano Santi, Giorgio Ercolani, Flavia Foca, Linda Valmorri, Dino Amadori and Giovanni Luca Frassinetiadd
Show full author list
remove
Hide full author list
Link:
https://www.mdpi.com/2072-6694/12/10/2790
MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover
and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article
and designed to be complimentary to the journal.
Cite
Monti, M.; Morgagni, P.; Nanni, O.; Framarini, M.; Saragoni, L.; Marrelli, D.; Roviello, F.; Petrioli, R.; Fumagalli Romario, U.; Rimassa, L.; et al. Preoperative or Perioperative Docetaxel, Oxaliplatin, and Capecitabine (GASTRODOC Regimen) in Patients with Locally-Advanced Resectable Gastric Cancer: A Randomized Phase-II Trial. Cancers 2020, 12, 2790. https://doi.org/10.3390/cancers12102790
Monti M, Morgagni P, Nanni O, Framarini M, Saragoni L, Marrelli D, Roviello F, Petrioli R, Fumagalli Romario U, Rimassa L, et al. Preoperative or Perioperative Docetaxel, Oxaliplatin, and Capecitabine (GASTRODOC Regimen) in Patients with Locally-Advanced Resectable Gastric Cancer: A Randomized Phase-II Trial. Cancers. 2020; 12(10):2790. https://doi.org/10.3390/cancers12102790
Chicago/Turabian StyleMonti, Manlio, Paolo Morgagni, Oriana Nanni, Massimo Framarini, Luca Saragoni, Daniele Marrelli, Franco Roviello, Roberto Petrioli, Uberto Fumagalli Romario, Lorenza Rimassa, and et al. 2020. "Preoperative or Perioperative Docetaxel, Oxaliplatin, and Capecitabine (GASTRODOC Regimen) in Patients with Locally-Advanced Resectable Gastric Cancer: A Randomized Phase-II Trial" Cancers 12, no. 10: 2790. https://doi.org/10.3390/cancers12102790
APA StyleMonti, M., Morgagni, P., Nanni, O., Framarini, M., Saragoni, L., Marrelli, D., Roviello, F., Petrioli, R., Fumagalli Romario, U., Rimassa, L., Bozzarelli, S., Donini, A., Graziosi, L., De Angelis, V., De Manzoni, G., Bencivenga, M., Mengardo, V., Parma, E., Milandri, C., ... Frassineti, G. L. (2020). Preoperative or Perioperative Docetaxel, Oxaliplatin, and Capecitabine (GASTRODOC Regimen) in Patients with Locally-Advanced Resectable Gastric Cancer: A Randomized Phase-II Trial. Cancers, 12(10), 2790. https://doi.org/10.3390/cancers12102790